Chinese robotics company Unitree Robotics said on Monday, August 10, 2026, that its $900 million Shanghai IPO was more than 8,000 times oversubscribed by retail investors — a record-setting demand signal as the company becomes the first onshore-listed humanoid robot maker in China.
Vanishing-Odds Lottery for Retail Buyers
Unitree said in a filing that the lot-winning rate for retail investors was roughly 0.018% after part of the institutional tranche was clawed back to satisfy demand, giving individual buyers worse odds than most other 2026 China IPOs. The offering was priced last week at 150.80 yuan (~$22.36) per share, valuing the Hangzhou-based company at more than 60 billion yuan (~$9 billion), or about 219 times 2025 earnings.
A Landmark for China's Humanoid Sector
Unitree, founded in 2016 by engineer Wang Xingxing, first became known for relatively inexpensive quadruped robots — Boston Dynamics' rivals — before turning to bipedal humanoids. It now competes head-to-head with Tesla and Boston Dynamics for the humanoid workload, and its Shanghai listing has become a proxy for investor conviction in the whole Chinese physical-AI stack. "The relatively high IPO valuation could draw market attention toward commercial value of the robotics industry," SWS Research analysts wrote, adding it may drive a re-rating of related listed names.
Fever, Risks, and What's Next
Not everyone is euphoric: some Shanghai fund managers point to a broader tech selloff and note that Unitree still books most of its revenue from research and demo units. The company has also flagged U.S. sales restrictions as a geopolitical risk. The listing follows Unitree's earlier IPO plan disclosure, sits alongside its ongoing product cadence including the consumer humanoid race led by 1X Neo, and pairs with fresh capital deployed into rivals like Neura Robotics.
Reporting based on Reuters, Bloomberg and CNBC coverage.